Insider Transactions in Q4 2022 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,500
-1.63%
|
$287,500
$23.1 P/Share
|
|
Nov 09
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
30,000
-3.69%
|
-
|
|
Nov 08
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,374
-3.12%
|
$284,602
$23.56 P/Share
|
|
Nov 07
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,500
-1.53%
|
$287,500
$23.95 P/Share
|
|
Oct 17
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,500
-2.96%
|
$287,500
$23.51 P/Share
|
|
Oct 06
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-2.32%
|
$220,000
$22.62 P/Share
|
|
Oct 05
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,500
-1.42%
|
$275,000
$22.38 P/Share
|
|
Oct 03
2022
|
Epperly Melissa B, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+14.39%
|
-
|
|
Oct 03
2022
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+5.79%
|
-
|
|
Oct 03
2022
|
Carrie Brownstein Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|